Popular

• 

  RestartResume

  No Patient with CKD Left Behind! Emerging CKD Therapies in T1D

  CME/CE

  No Patient with CKD Left Behind! Emerging CKD Therapies in T1D

  • 

    

    Richard E. Pratley, MD

    Peer

  • 

    

    David Cherney, MD, PhD

    Peer

  • 

    

    prof. Hiddo Heerspink

    Peer

  0.50 credits

• 

  RestartResume

  Progress in Breast Cancer Care: Translating SABCS Data Into Practice

  CME/CE

  Progress in Breast Cancer Care: Translating SABCS Data Into Practice

  • 

    

    Charles E. Geyer Jr., MD, FACP

    Peer

  • 

    

    Komal Jhaveri, MD, FACP

    Peer

  0.25 credits

• 

  RestartResume

  Navigating Treatment Sequencing After Frontline Treatment Failure in CLL

  CME/CE

  Navigating Treatment Sequencing After Frontline Treatment Failure in CLL

  • 

    

    Jennifer R. Brown, MD, PhD

    Peer

  0.25 credits

• 

  RestartResume

  Double-Class Refractory CLL in Community Practice: Current and Future Management

  CME/CE

  Double-Class Refractory CLL in Community Practice: Current and Future Management

  • 

    

    John C. Byrd, MD

    Peer

  0.25 credits

• 

  RestartResume

  Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction

  CME/CE

  Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction

  • 

    

    Stephen J. Greene, MD, FACC, FHFSA

    Peer

  • 

    

    Gianluigi Savarese, MD

    Peer

  0.25 credits

• 

  RestartResume

  Mental Health Implications in Psoriasis

  Practical Dermatology: IL-17 Journal Club

  Mental Health Implications in Psoriasis

  • 

    

    Neal Bhatia, MD

    Peer

  • 

    

    Andrew Blauvelt, MD, MBA

    Peer

• 

  RestartResume

  Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  • 

    

    David Chin Yee, MD, FASRS

    Peer

  0.25 credits

• 

  RestartResume

  Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management

  Heart Matters

  Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management

  • 

    

    Saurabh Malhotra, MD, MPH, FASNC

    Peer

  • 

    

    Cigdem Akincioglu, MD, FASNC

    Peer

  • 

    

    Kevin Alexander, MD

    Peer

  • 

    

    Katherine Lee Chuy, MD

    Peer

  • 

    

    Angela Dispenzieri, MD

    Peer

  • 

    

    Sharmila Dorbala, MD, MPH, MASNC

    Peer

  • 

    

    Cesia Gallegos-Kattán, MD, MHS, FASNC

    Peer

  • 

    

    Wael Jaber, MD, FASNC

    Peer

  • 

    

    Mike Lane

    Peer

  • 

    

    Ahmad Masri, MD, MS

    Peer

  • 

    

    Mathew S. Maurer, MD

    Peer

  • 

    

    Frederick Ruberg, MD

    Peer

  • 

    

    Prem Soman, MD, PhD, MASNC

    Peer

  • 

    

    Brett Sperry, MD, FASNC

    Peer

  • 

    

    Andrew Staron, MD

    Peer

  • 

    

    Jonathan Wall, PhD

    Peer

  • 

    

    Ashutosh Wechalekar, MBBS, MD

    Peer

  • 

    

    David Wolinsky, MD, MASNC

    Peer

  • 

    

    Sasha Zivkovic, MD, PhD

    Peer

  • 

    

    A Sami Abuzaid, MD, FASNC

    Peer

  • 

    

    Vasvi Singh, MD, FASNC

    Peer

  • 

    

    Mark Hyun, CNMT, NCT, RS, RT(N,R,CT), FASNC

    Peer

  • 

    

    Maria Mackin, BS, MS, CNMT, RT (N), LNMT, FASNC

    Peer

  • 

    

    Ronald G. Schwartz, MD, MS, MASNC

    Peer

• 

  RestartResume

  Closing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025

  Heart Matters

  Closing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025

  • 

    

    Laurence Sperling, MD

    Peer

  • 

    

    Eugenia Gianos, MD

    Peer

• 

  RestartResume

  A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  • 

    

    Esther Lee Kim, MD

    Peer

  0.25 credits

• 

  RestartResume

  Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA

  Medical Industry Feature

  Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA

• 

  RestartResume

  Early Approaches to RAS Targeting: Efficacy Signals and Known Limitations

  MinuteCE®

  Early Approaches to RAS Targeting: Efficacy Signals and Known Limitations

  • 

    

    Kathryn Arbour

    Peer

  • 

    

    Eileen M. O'Reilly, MD

    Peer

  0.75 program credits

• 

  RestartResume

  Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer

  MinuteCE®

  Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer

  • 

    

    Kathryn Arbour

    Peer

  • 

    

    Eileen M. O'Reilly, MD

    Peer

  0.75 program credits

• 

  RestartResume

  It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  • 

    

    David Eichenbaum, MD

    Peer

  0.25 credits

• 

  RestartResume

  OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA

  Global Neurology Academy

  OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA

  • 

    

    Mike Sharma, MD, MSc, FRCPC

    Peer